Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes
Related Experiment Videos
Cancer Chemotherapy and Pharmacology
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcome of Temporalis Myofascial Flap in Maxillary Reconstruction.
Mymensingh medical journal : MMJ·2026
Genetic testing for spinocerebellar ataxias in patients diagnosed as Parkinson's disease in Bangladesh.
Mymensingh medical journal : MMJ·2015
Glutathione S-transferase π-isoform is not altered in bladder tissue from smokers.
Urologic oncology·2011
Irreversible inhibition of CYP2D6 by (-)-chloroephedrine, a possible impurity in methamphetamine.
Drug metabolism and disposition: the biological fate of chemicals·2002
Characterization of quinidine 3-hydroxylation as a probe for the CYP 3A enzyme using a novel capillary electrophoresis technique.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2002
Persistence and metabolism of imidacloprid in different soils of West Bengal.
Pest management science·2001
The role of tyrosine kinase inhibitors as a post-hematopoietic stem cell transplant continuation therapy for pediatric acute leukemia: a systematic review.
Cancer chemotherapy and pharmacology·2026
Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations.
Cancer chemotherapy and pharmacology·2026
Translational applications and clinical utility of organoids in ovarian cancer: a systematic review.
Cancer chemotherapy and pharmacology·2026
Protective effect of N-acetylcysteine on oxaliplatin-induced peripheral neuropathy in colorectal cancer: a randomized controlled trial.
Cancer chemotherapy and pharmacology·2026
Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report.
Cancer chemotherapy and pharmacology·2026
Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II-III colon cancer.
Cancer chemotherapy and pharmacology·2026